About Echo

Echo Therapeutics is a medical device company with deep expertise in advanced skin permeation technology. Echo is developing its Prelude® SkinPrep System as a platform technology to allow for enhanced skin permeation that will enable two important applications:

Analyte extraction, with the Symphony® CGM System for needle-free, continuous glucose monitoring in critical patients as the first application.

Needle-free drug delivery, with the delivery of lidocaine as the first application.

Echo believes that transdermal drug delivery and analyte monitoring is a much better way of patient care than the current paradigm of invasive, needle-based therapy. Prelude has the potential to provide an easy-to-use and cost effective skin permeation process that Echo believes will increase patient comfort, compliance and ultimately patient outcomes.